Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

No human lung cell data, no human trials,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (13) | Next 10 | Previous | Next
Stan Dango Member Profile
 
Followed By 1
Posts 12
Boards Moderated 0
Alias Born 04/20/20
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/15/2020 10:02:03 AM
Annual Report (10-k) Edgar (US Regulatory) - 9/14/2020 4:51:25 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/4/2020 9:32:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 9:30:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2020 10:01:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2020 3:10:16 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/20/2020 6:03:30 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/15/2020 10:56:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/10/2020 5:09:32 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/10/2020 3:07:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:28:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2020 2:16:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2020 9:33:35 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 9:03:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 9:30:58 AM
Cannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here! InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2020 2:21:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/1/2020 4:39:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 12:00:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2020 12:01:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/27/2020 12:01:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2020 4:06:02 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/13/2020 4:02:49 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/26/2019 5:19:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/26/2019 5:16:58 PM
Stan Dango   Thursday, 06/11/20 08:26:17 AM
Re: Dr._Paddleboarder post# 300880
Post # of 324468 
No human lung cell data, no human trials, just a grant application

It should be obvious by now that the ship for B for C has sailed. Now they dish out a PR saying they’re collaborating on a grant to study B as a broad spectrum antiviral. This is really the only hope for B - that it may get free money to study its application elsewhere. After all this time, and all the PR’s promising human lung cell data and to rapidly advance B into human trials, you’ve got Petri dish testing in monkey veto cells and a human kidney cell line. No lung data, no human trials. Just someone to help them fill a grant application out.

Oh, the researchers are going to publish their data after completion of in in vitro testing? No crap, that’s what researchers do. Here I’ll tell you exactly what it’ll say “While B did not show efficacy against SARS-cov-2 in human lung cells in vitro, it may potentially have applications elsewhere.” Only problem is the company is broke and “elsewhere” isn’t what the last dozen PR’s were promising.





Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (13) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences